Actinium Pharmaceuticals Inc (NYSE American:ATNM)

0.7284
Delayed Data
As of 8:00pm ET
 -0.0016 / -0.22%
Today’s Change
0.33
Today|||52-Week Range
0.85
+9.76%
Year-to-Date
No recent news for Actinium Pharmaceuticals Inc.

Today’s Trading

Previous close0.73
Today’s open0.72
Day’s range0.71 - 0.74
Volume503,518
Average volume (3 months)1,443,698
Market cap$80.6M
Data as of 8:00pm ET, 09/20/2018

Growth & Valuation

Earnings growth (last year)+20.00%
Earnings growth (this year)--
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.28

Competitors

 Today’s
change
Today’s
% change
SPHSSophiris Bio Inc-0.02-0.75%
GNMXAevi Genomic Medicin...0.000.00%
OTICOtonomy Inc0.000.00%
ORMPOramed Pharmaceutica...+0.11+2.32%
Data as of 4:00pm ET, 09/20/2018

Financials

Next reporting dateOctober 26, 2018
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$26.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Executive Officer
Sandesh Seth
Principal Financial &
Accounting Officer
Steve Oloughlin
Corporate headquarters
New York, New York

Forecasts